About Us

Eternity Bioscience, Inc. (EBI) was founded in 2009 by Jiangsu Hengrui Medicine. With a market capitalization of over $30 billion, Jiangsu Hengrui Medicine ranks as one of the top 30 pharmaceutical companies worldwide and employs more than 21,000 employees.

Over 3,200 research scientists work in one of the ten research centers around the globe. As Hengui's New Jersey R&D center, our mission is to deliver innovative first-in-class and/or best-in-class drug candidates for unmet medical needs.

Learn more about Jiangsu Hengrui Medicine's global R&D centers as well as Jiangsu Hengrui Medicine's New Jersey based clinical development biotech Hengrui Therapeutics.



Our Approach

By coupling the biological insights determined during target selection with structure-guided small molecule design, EBI scientists rapidly advance leads to clinical candidates.

Management Team

Chief Scientific Officer

Head of Chemistry

Head of Biology